Copyright Reports & Markets. All rights reserved.

Global Locked Nucleic Acids (LNA) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Locked Nucleic Acids (LNA) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 High Affinity LNA
    • 1.3.3 Adjustable LNA
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Locked Nucleic Acids (LNA) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Basic research
    • 1.4.3 Clinical diagnosis
    • 1.4.4 Drug development
  • 1.5 Global Locked Nucleic Acids (LNA) Market Size & Forecast
    • 1.5.1 Global Locked Nucleic Acids (LNA) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Locked Nucleic Acids (LNA) Sales Quantity (2020-2031)
    • 1.5.3 Global Locked Nucleic Acids (LNA) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Ajinomoto Bio-Pharma
    • 2.1.1 Ajinomoto Bio-Pharma Details
    • 2.1.2 Ajinomoto Bio-Pharma Major Business
    • 2.1.3 Ajinomoto Bio-Pharma Locked Nucleic Acids (LNA) Product and Services
    • 2.1.4 Ajinomoto Bio-Pharma Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Ajinomoto Bio-Pharma Recent Developments/Updates
  • 2.2 Medtide Inc.
    • 2.2.1 Medtide Inc. Details
    • 2.2.2 Medtide Inc. Major Business
    • 2.2.3 Medtide Inc. Locked Nucleic Acids (LNA) Product and Services
    • 2.2.4 Medtide Inc. Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Medtide Inc. Recent Developments/Updates
  • 2.3 BOC Sciences
    • 2.3.1 BOC Sciences Details
    • 2.3.2 BOC Sciences Major Business
    • 2.3.3 BOC Sciences Locked Nucleic Acids (LNA) Product and Services
    • 2.3.4 BOC Sciences Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 BOC Sciences Recent Developments/Updates
  • 2.4 QIAGEN
    • 2.4.1 QIAGEN Details
    • 2.4.2 QIAGEN Major Business
    • 2.4.3 QIAGEN Locked Nucleic Acids (LNA) Product and Services
    • 2.4.4 QIAGEN Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 QIAGEN Recent Developments/Updates
  • 2.5 LGC Group
    • 2.5.1 LGC Group Details
    • 2.5.2 LGC Group Major Business
    • 2.5.3 LGC Group Locked Nucleic Acids (LNA) Product and Services
    • 2.5.4 LGC Group Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 LGC Group Recent Developments/Updates
  • 2.6 Kaneka Eurogentec SA (Eurogentec)
    • 2.6.1 Kaneka Eurogentec SA (Eurogentec) Details
    • 2.6.2 Kaneka Eurogentec SA (Eurogentec) Major Business
    • 2.6.3 Kaneka Eurogentec SA (Eurogentec) Locked Nucleic Acids (LNA) Product and Services
    • 2.6.4 Kaneka Eurogentec SA (Eurogentec) Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Kaneka Eurogentec SA (Eurogentec) Recent Developments/Updates
  • 2.7 biomers.net GmbH
    • 2.7.1 biomers.net GmbH Details
    • 2.7.2 biomers.net GmbH Major Business
    • 2.7.3 biomers.net GmbH Locked Nucleic Acids (LNA) Product and Services
    • 2.7.4 biomers.net GmbH Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 biomers.net GmbH Recent Developments/Updates
  • 2.8 Ella Biotech GmbH
    • 2.8.1 Ella Biotech GmbH Details
    • 2.8.2 Ella Biotech GmbH Major Business
    • 2.8.3 Ella Biotech GmbH Locked Nucleic Acids (LNA) Product and Services
    • 2.8.4 Ella Biotech GmbH Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Ella Biotech GmbH Recent Developments/Updates
  • 2.9 Eurofins Genomics LLC
    • 2.9.1 Eurofins Genomics LLC Details
    • 2.9.2 Eurofins Genomics LLC Major Business
    • 2.9.3 Eurofins Genomics LLC Locked Nucleic Acids (LNA) Product and Services
    • 2.9.4 Eurofins Genomics LLC Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Eurofins Genomics LLC Recent Developments/Updates
  • 2.10 Azenta Life Sciences
    • 2.10.1 Azenta Life Sciences Details
    • 2.10.2 Azenta Life Sciences Major Business
    • 2.10.3 Azenta Life Sciences Locked Nucleic Acids (LNA) Product and Services
    • 2.10.4 Azenta Life Sciences Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Azenta Life Sciences Recent Developments/Updates
  • 2.11 SHIKOKURIKA CO.,LTD
    • 2.11.1 SHIKOKURIKA CO.,LTD Details
    • 2.11.2 SHIKOKURIKA CO.,LTD Major Business
    • 2.11.3 SHIKOKURIKA CO.,LTD Locked Nucleic Acids (LNA) Product and Services
    • 2.11.4 SHIKOKURIKA CO.,LTD Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 SHIKOKURIKA CO.,LTD Recent Developments/Updates
  • 2.12 SBS Genetech
    • 2.12.1 SBS Genetech Details
    • 2.12.2 SBS Genetech Major Business
    • 2.12.3 SBS Genetech Locked Nucleic Acids (LNA) Product and Services
    • 2.12.4 SBS Genetech Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 SBS Genetech Recent Developments/Updates
  • 2.13 Zhscience
    • 2.13.1 Zhscience Details
    • 2.13.2 Zhscience Major Business
    • 2.13.3 Zhscience Locked Nucleic Acids (LNA) Product and Services
    • 2.13.4 Zhscience Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Zhscience Recent Developments/Updates
  • 2.14 Blossom Biotechnologies Inc.
    • 2.14.1 Blossom Biotechnologies Inc. Details
    • 2.14.2 Blossom Biotechnologies Inc. Major Business
    • 2.14.3 Blossom Biotechnologies Inc. Locked Nucleic Acids (LNA) Product and Services
    • 2.14.4 Blossom Biotechnologies Inc. Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Blossom Biotechnologies Inc. Recent Developments/Updates
  • 2.15 Genecfps
    • 2.15.1 Genecfps Details
    • 2.15.2 Genecfps Major Business
    • 2.15.3 Genecfps Locked Nucleic Acids (LNA) Product and Services
    • 2.15.4 Genecfps Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Genecfps Recent Developments/Updates
  • 2.16 GenScript
    • 2.16.1 GenScript Details
    • 2.16.2 GenScript Major Business
    • 2.16.3 GenScript Locked Nucleic Acids (LNA) Product and Services
    • 2.16.4 GenScript Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 GenScript Recent Developments/Updates
  • 2.17 RIBO Pharm
    • 2.17.1 RIBO Pharm Details
    • 2.17.2 RIBO Pharm Major Business
    • 2.17.3 RIBO Pharm Locked Nucleic Acids (LNA) Product and Services
    • 2.17.4 RIBO Pharm Locked Nucleic Acids (LNA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 RIBO Pharm Recent Developments/Updates

3 Competitive Environment: Locked Nucleic Acids (LNA) by Manufacturer

  • 3.1 Global Locked Nucleic Acids (LNA) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Locked Nucleic Acids (LNA) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Locked Nucleic Acids (LNA) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Locked Nucleic Acids (LNA) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Locked Nucleic Acids (LNA) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Locked Nucleic Acids (LNA) Manufacturer Market Share in 2024
  • 3.5 Locked Nucleic Acids (LNA) Market: Overall Company Footprint Analysis
    • 3.5.1 Locked Nucleic Acids (LNA) Market: Region Footprint
    • 3.5.2 Locked Nucleic Acids (LNA) Market: Company Product Type Footprint
    • 3.5.3 Locked Nucleic Acids (LNA) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Locked Nucleic Acids (LNA) Market Size by Region
    • 4.1.1 Global Locked Nucleic Acids (LNA) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Locked Nucleic Acids (LNA) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Locked Nucleic Acids (LNA) Average Price by Region (2020-2031)
  • 4.2 North America Locked Nucleic Acids (LNA) Consumption Value (2020-2031)
  • 4.3 Europe Locked Nucleic Acids (LNA) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Locked Nucleic Acids (LNA) Consumption Value (2020-2031)
  • 4.5 South America Locked Nucleic Acids (LNA) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Locked Nucleic Acids (LNA) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Locked Nucleic Acids (LNA) Sales Quantity by Type (2020-2031)
  • 5.2 Global Locked Nucleic Acids (LNA) Consumption Value by Type (2020-2031)
  • 5.3 Global Locked Nucleic Acids (LNA) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Locked Nucleic Acids (LNA) Sales Quantity by Application (2020-2031)
  • 6.2 Global Locked Nucleic Acids (LNA) Consumption Value by Application (2020-2031)
  • 6.3 Global Locked Nucleic Acids (LNA) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Locked Nucleic Acids (LNA) Sales Quantity by Type (2020-2031)
  • 7.2 North America Locked Nucleic Acids (LNA) Sales Quantity by Application (2020-2031)
  • 7.3 North America Locked Nucleic Acids (LNA) Market Size by Country
    • 7.3.1 North America Locked Nucleic Acids (LNA) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Locked Nucleic Acids (LNA) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Locked Nucleic Acids (LNA) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Locked Nucleic Acids (LNA) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Locked Nucleic Acids (LNA) Market Size by Country
    • 8.3.1 Europe Locked Nucleic Acids (LNA) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Locked Nucleic Acids (LNA) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Locked Nucleic Acids (LNA) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Locked Nucleic Acids (LNA) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Locked Nucleic Acids (LNA) Market Size by Region
    • 9.3.1 Asia-Pacific Locked Nucleic Acids (LNA) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Locked Nucleic Acids (LNA) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Locked Nucleic Acids (LNA) Sales Quantity by Type (2020-2031)
  • 10.2 South America Locked Nucleic Acids (LNA) Sales Quantity by Application (2020-2031)
  • 10.3 South America Locked Nucleic Acids (LNA) Market Size by Country
    • 10.3.1 South America Locked Nucleic Acids (LNA) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Locked Nucleic Acids (LNA) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Locked Nucleic Acids (LNA) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Locked Nucleic Acids (LNA) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Locked Nucleic Acids (LNA) Market Size by Country
    • 11.3.1 Middle East & Africa Locked Nucleic Acids (LNA) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Locked Nucleic Acids (LNA) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Locked Nucleic Acids (LNA) Market Drivers
  • 12.2 Locked Nucleic Acids (LNA) Market Restraints
  • 12.3 Locked Nucleic Acids (LNA) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Locked Nucleic Acids (LNA) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Locked Nucleic Acids (LNA)
  • 13.3 Locked Nucleic Acids (LNA) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Locked Nucleic Acids (LNA) Typical Distributors
  • 14.3 Locked Nucleic Acids (LNA) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Locked Nucleic Acids (LNA) market size was valued at US$ 1971 million in 2024 and is forecast to a readjusted size of USD 3302 million by 2031 with a CAGR of 7.7% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Locked Nucleic Acids (LNA) were first independently described in 1997 by Jesper Wengel1 and Takeshi Imanishi2 and have become an important part of hybridisation-based applications.LNAs are a class of modified RNA-nucleic acid analogues that have an additional methylene bridge. This linkage connects the oxygen atom at the C-2´ of the ribose with the 4´-carbon atom and helps to fix the ribose ring in the 3'-endo conformation (""locked"") which leads to the characteristic A-RNA structure and to the exclusive formation of
    A-duplexes.
    This report is a detailed and comprehensive analysis for global Locked Nucleic Acids (LNA) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Locked Nucleic Acids (LNA) market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
    Global Locked Nucleic Acids (LNA) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
    Global Locked Nucleic Acids (LNA) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
    Global Locked Nucleic Acids (LNA) market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Locked Nucleic Acids (LNA)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Locked Nucleic Acids (LNA) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ajinomoto Bio-Pharma, Medtide Inc., BOC Sciences, QIAGEN, LGC Group, Kaneka Eurogentec SA (Eurogentec), biomers.net GmbH, Ella Biotech GmbH, Eurofins Genomics LLC, Azenta Life Sciences, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Locked Nucleic Acids (LNA) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    High Affinity LNA
    Adjustable LNA
    Market segment by Application
    Basic research
    Clinical diagnosis
    Drug development
    Major players covered
    Ajinomoto Bio-Pharma
    Medtide Inc.
    BOC Sciences
    QIAGEN
    LGC Group
    Kaneka Eurogentec SA (Eurogentec)
    biomers.net GmbH
    Ella Biotech GmbH
    Eurofins Genomics LLC
    Azenta Life Sciences
    SHIKOKURIKA CO.,LTD
    SBS Genetech
    Zhscience
    Blossom Biotechnologies Inc.
    Genecfps
    GenScript
    RIBO Pharm
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Locked Nucleic Acids (LNA) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Locked Nucleic Acids (LNA), with price, sales quantity, revenue, and global market share of Locked Nucleic Acids (LNA) from 2020 to 2025.
    Chapter 3, the Locked Nucleic Acids (LNA) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Locked Nucleic Acids (LNA) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Locked Nucleic Acids (LNA) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Locked Nucleic Acids (LNA).
    Chapter 14 and 15, to describe Locked Nucleic Acids (LNA) sales channel, distributors, customers, research findings and conclusion.

    Buy now